---
title: 'The effect of estradiol add-back: a longitudinal MRI study in prostate cancer
  patients'
date: '2024-01-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38226639/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240116170636&v=2.18.0
source: heidelberg[Affiliation]
description: We investigated the effect of estradiol add-back therapy (EAT) on brain
  activation related to cognitive function and affect in addition to putative changes
  in grey and white matter volume in testosterone depleted participants with prostate
  cancer. We conducted a randomized controlled, double-blinded trial in which 40 patients
  received 0.9 mg of transdermal estradiol per day for six months or matched placebo.
  Anatomical MRI and three functional MRI (fMRI) scans were obtained for the ...
disable_comments: true
---
We investigated the effect of estradiol add-back therapy (EAT) on brain activation related to cognitive function and affect in addition to putative changes in grey and white matter volume in testosterone depleted participants with prostate cancer. We conducted a randomized controlled, double-blinded trial in which 40 patients received 0.9 mg of transdermal estradiol per day for six months or matched placebo. Anatomical MRI and three functional MRI (fMRI) scans were obtained for the ...